Shukla Sanjay 4
4 · aTYR PHARMA INC · Filed Jan 9, 2026
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2026-01-09+1,500,000→ 1,500,000 totalExercise: $0.71Exp: 2036-01-09→ Common Stock (1,500,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning February 9, 2026, such that this option will be fully exercisable on January 9, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.